Food and Cosmetics
Our team regularly advises clients developing biotech products in areas including biotechnology derived proteins (such as insulin), immunologicals (such as vaccines and allergens), blood or plasma derived products, and engineered tissues.
Our Life Sciences team has experience of advising many cosmetic and food companies, including Cargill, LVMH Perfumes and Cosmetics, Primark, United Biscuits, McDonalds, Heineken, Kraft Foods Inc, Nestlé, British Sugar and Heinz, among others. We have advised on issues including health claims, composition and labelling requirements, and various marketing issues. Our lawyers know the issues the industry faces and understand how to deal with them. The team has the added benefit of being fully integrated into Allen & Overy’s broader Life Sciences team and benefits from insights and expertise from our dedicated Life Sciences regulatory group.
Explore our sectors
Meet our lawyers
News & insights
News: 10 JULY 2020
Allen & Overy has advised the joint sponsors on the global offering and listing of shares of Immunotech Biopharm Ltd (Immunotech Biopharm) on the Hong Kong Stock Exchange under Chapter 18A of the…
Read more
Publications: 08 JULY 2020
Pipeline gaps and digital will drive life sciences deals
Often seen as a safe haven sector in times of crisis, the life sciences have not only been centre stage during the Covid-19 coronavirus crisis but are riding it out well.
Read more
Publications: 08 JULY 2020
China maintains outward-looking approach
The Covid-19 coronavirus crisis has slowed Chinese deal activity. Activity remains sluggish even though the country is emerging from the crisis earlier than the rest of the world.
Read more
Publications: 08 JULY 2020
A market utterly transformed, as M&A deals stall
The Covid-19 coronavirus pandemic has brought the global M&A market to a juddering halt and is likely to radically change dealmaking for the foreseeable future.
Read moreDownload our sector brochure
